ROMAGNOLI, Dante
 Distribuzione geografica
Continente #
NA - Nord America 3.142
EU - Europa 1.077
AS - Asia 462
OC - Oceania 10
AF - Africa 9
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 4.714
Nazione #
US - Stati Uniti d'America 3.130
GB - Regno Unito 323
IT - Italia 223
CN - Cina 168
SG - Singapore 154
SE - Svezia 153
DE - Germania 151
UA - Ucraina 54
HK - Hong Kong 50
FI - Finlandia 37
TR - Turchia 37
BG - Bulgaria 27
FR - Francia 25
LT - Lituania 24
ID - Indonesia 14
RU - Federazione Russa 13
VN - Vietnam 11
AU - Australia 9
BE - Belgio 9
CA - Canada 9
IN - India 9
BR - Brasile 7
IE - Irlanda 7
CZ - Repubblica Ceca 6
MY - Malesia 6
NL - Olanda 6
EU - Europa 5
SI - Slovenia 4
AT - Austria 3
ES - Italia 3
ET - Etiopia 3
IR - Iran 3
CH - Svizzera 2
DK - Danimarca 2
JP - Giappone 2
MX - Messico 2
PK - Pakistan 2
TJ - Tagikistan 2
ZA - Sudafrica 2
AR - Argentina 1
BD - Bangladesh 1
BZ - Belize 1
EG - Egitto 1
GH - Ghana 1
HR - Croazia 1
HU - Ungheria 1
KR - Corea 1
MK - Macedonia 1
MU - Mauritius 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
PL - Polonia 1
RO - Romania 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 4.714
Città #
Fairfield 505
Woodbridge 295
Chandler 253
Ashburn 248
Southend 246
Seattle 244
Houston 238
Wilmington 186
Santa Clara 169
Cambridge 153
Singapore 135
Nyköping 125
Dearborn 123
Ann Arbor 99
Jacksonville 77
Modena 77
New York 51
Hong Kong 46
Beijing 35
San Diego 34
Izmir 32
Helsinki 28
Sofia 27
Princeton 26
Eugene 25
Shanghai 17
Jakarta 14
London 14
Redwood City 14
Guangzhou 11
Dong Ket 10
Fremont 10
Bologna 9
Bremen 9
Brussels 9
Padova 8
San Mateo 8
Carpi 7
Dublin 7
Nanjing 7
Brno 6
Hefei 6
Munich 6
Rome 6
Boardman 5
Grafing 5
Phoenix 5
Florence 4
Frankfurt am Main 4
Livorno 4
Milan 4
Norwalk 4
Sydney 4
Toronto 4
Addis Ababa 3
Augusta 3
Bareggio 3
Casteldaccia 3
Lecce 3
Legnaro 3
Los Angeles 3
Monmouth Junction 3
Ottawa 3
Roncoferraro 3
São Paulo 3
Vienna 3
Abbiategrasso 2
Acton 2
Ardabil 2
Barcelona 2
Betton 2
Canberra 2
Castellana Grotte 2
Chicago 2
Chiswick 2
Council Bluffs 2
Falls Church 2
Fano 2
Ferrara 2
Genoa 2
Hangzhou 2
Hebei 2
Jinan 2
Kai Yi Wan 2
Kunming 2
Lanzhou 2
Leawood 2
Leno 2
Melegnano 2
Meppel 2
Muizenberg 2
Naples 2
Napoli 2
New Delhi 2
Palermo 2
Paris 2
Pogliano Milanese 2
Prescot 2
Randers 2
Regensburg 2
Totale 3.802
Nome #
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals 310
Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma 248
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis 223
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 216
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 203
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 203
NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk 200
Nonalcoholic fatty liver disease and aging: epidemiology to management 198
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease-Evidence from three different disease models: NAFLD, HCV and HIV 196
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 187
Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease? 187
Nonalcoholic steatohepatitis heralding olmesartan-induced sprue-like enteropathy 176
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen 176
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis 173
Type 2 diabetes in non-alcoholic fatty liver disease and hepatitis c virus infection—liver: The “Musketeer” in the spotlight 151
Alcohol and Steatosis: The Japanese Paradox 148
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 147
Urology in the Time of Coronavirus: Reduced Access to Urgent and Emergent Urological Care during the Coronavirus Disease 2019 Outbreak in Italy 146
Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases 142
The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans 137
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 137
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 126
Do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent? 122
Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications 121
The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment 94
Gender differences in chronic alcoholic and viral liver diseases 79
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 65
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma 60
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 56
Prognostic significance of hypoxic and metabolic gene profiling in hepatocellular carcinoma 46
Dynamic Angiopoietin-2 Serum Level as Endothelial Damage Marker and Potential Therapeutic Target 45
Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma 37
Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy 30
Totale 4.785
Categoria #
all - tutte 22.155
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.155


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020841 0 0 0 0 101 187 195 123 113 39 59 24
2020/20211.001 73 40 74 86 106 116 76 130 54 96 96 54
2021/2022523 46 51 19 20 14 37 25 28 68 46 119 50
2022/2023691 68 90 61 77 67 77 15 74 75 9 35 43
2023/2024465 23 33 57 33 71 47 19 36 19 7 52 68
2024/2025383 30 13 39 105 196 0 0 0 0 0 0 0
Totale 4.785